Temperature-stable tuberculosis vaccine prompts immune response 12-Apr-2023 By Rachel Arthur A Phase 1 trial found that a freeze-dried, temperature-stable experimental tuberculosis vaccine was safe, well-tolerated and elicited robust antigen-specific serum antibody and Th1-type cellular immune responses.